

Fundamental dimension Equity attribute | LWAYLeader $22.46▼-2.01% Cap $339.3MP/E 31.3x QuantScore71/100 | BGSPeer $2.10▼-2.33% Cap $170.7MP/E -2.4x QuantScore36/100 | BRCCPeer $11.30▲+1.71% Cap $359.5MP/E -33.7x QuantScore31/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
64/100 |
23/100 |
74/100 |
Valuation Multiples, PEG & DCF upside | 57/100 | 76/100 | 7/100 |
Health Piotroski, Altman Z, leverage & liquidity | 87/100 | 13/100 | 34/100 |
Growth Revenue / earnings growth & margins | 56/100 | 21/100 | 21/100 |
Sentiment Analyst ratings, targets & revisions | 90/100 | 50/100 | 20/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 31.3x | -2.4x | -33.7x |
Forward P/E (next FY) | 43.2x | 3.8x | 61.1x |
EV / EBITDA (TTM) | 17.8x | 14.9x | 70.8x |
Price / Sales | 1.4x | 0.1x | 0.8x |
Price / Free Cash Flow | -10.9x | 2.7x | 46.8x |
PEG ratio | 22.20 | 0.04 | -0.28 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 3 / 9 | 6 / 9 |
Altman Z-Score | 7.75 (Safe) | 0.95 (Distress) | 2.91 (Grey) |
Total debt / equity | 0.27 | 6.52 | 1.19 |
Quick ratio | 1.5x | 1.1x | 0.8x |
Interest coverage | 83.2x | 0.4x | -0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +13.7% | -5.4% | +1.7% |
Net income growth YoY | +53.6% | +82.8% | -303.6% |
Gross margin (TTM) | 26.0% | 21.5% | 33.9% |
Operating margin (FY) | 7.6% | 5.3% | -6.2% |
FCF margin (FY) | -7.7% | 3.9% | -3.4% |
5. Trailing price performancePrice change over period |
1M return | +2.5% | -30.5% | +25.0% |
3M return | -26.2% | -40.2% | +4.6% |
6M return | -18.8% | -60.7% | -2.6% |
Year to date | -7.3% | -51.2% | +1.8% |
1Y return | -14.6% | -53.0% | -19.3% |
3Y return | +79.2% | -74.9% | -58.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $37.10 +65.2% upside | $12.05 +473.8% upside | $-99.23 -978.1% premium |
Wall Street consensus target | $32.00 +42.5% · range $32.00–$32.00 | $3.83 +82.4% · range $3.00–$4.50 | $1.75 -84.5% · range $1.75–$1.75 |
Consensus stance | 71% Buy29% Hold0% Sell | 18% Buy65% Hold18% Sell | 36% Buy64% Hold0% Sell |